A Study of a Prebiotic, a Probiotic and a Synbiotic Upon the Gut Microbiota and Immune Response of Healthy Volunteers
XOS
A Double-blind, Placebo-controlled, Randomized Crossover Study to Determine the Effects of Xylooligosaccharides (XOS), B. Lactis (BI07) and XOS + BI07 Upon the Gut Microbiota and Immune Response of Healthy Volunteers
1 other identifier
interventional
44
1 country
1
Brief Summary
Healthy volunteers will be recruited to a study where they will be given four different treatments over a 28 week period. These treatments include: a prebiotic, a probiotic, a synbiotic (prebiotic + probiotic) and a placebo. Faecal samples, blood and saliva will be collected and analysed for changes in faecal microbial populations and selected immune responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 29, 2012
CompletedFirst Posted
Study publicly available on registry
March 6, 2012
CompletedMarch 7, 2012
March 1, 2012
1 year
February 29, 2012
March 6, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Changes to the gut microbiota
Changes in faecal bacterial populations will be assessed through the use of FISH with molecular probes targeting 16S rRNA genes. Genotypic probes targeting the predominant components of the gut microflora (Bacteroides, Bifidobacterium, Clostridium, Lactobacillus, Eubacterium, Atopobacterium, Streptococcus, sulphate reducing bacteria and enterobacteria) and total bacteria will be tagged with fluorescent markers such that quantifiable changes may be determined. Concentrations of short chain fatty acids (SCFA) will be quantified using gas chromatography (GC).
7 months
Secondary Outcomes (1)
Bowel function, immune function and plasma lipids
7 months
Study Arms (4)
Prebiotic
EXPERIMENTALProbiotic
EXPERIMENTALSynbiotic
EXPERIMENTALPlacebo
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- signed consent form
- age 25-65 years
- body mass index 20-30 inclusive
- good general health as determined by medical questionnaires
You may not qualify if:
- Evidence of physical or mental disease or planned major surgery, which might limit participation in or completion of the study
- History of drug abuse, including alcohol
- Severe allergy or a history of severe abnormal drug reaction
- Participation in experimental drug trial within four weeks prior to study
- Participation in prebiotics or laxative trial within the previous three months
- Use of antibiotics within the previous six months
- Chronic constipation, diarrhoea or other chronic gastro-intestinal complaint
- Intake of other prebiotics or probiotics, drugs active on gastrointestinal motility, or a laxative of any class for four weeks prior to study
- Use of prescribed medication
- Regular use of aspirin or other anti-inflammatory drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Readinglead
- Daniscocollaborator
Study Sites (1)
University of Reading
Reading, Berkshire, RG6 6AP, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Glenn R Gibson, BSc, PhD
University of Reading
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Post doctoral research fellow
Study Record Dates
First Submitted
February 29, 2012
First Posted
March 6, 2012
Study Start
September 1, 2008
Primary Completion
September 1, 2009
Study Completion
January 1, 2010
Last Updated
March 7, 2012
Record last verified: 2012-03